Company
VRG Therapeutics
- Biotech
- Location:
- Leiden, Netherlands
Description
VRG Therapeutics designs therapeutic miniproteins using a proprietary platform that combines AI-driven protein engineering with wet-lab directed evolution to create peptide- and protein-based therapeutics, including cell and gene therapy products.
VRG Therapeutics is located in the Netherlands ecosystem.
Related
EnzyTagEnzyTag develops peptiligase-based synthetic routes for manufacturing peptide new chemical entities, small proteins, and peptide…
NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
TQ TherapeuticsTQ Therapeutics operates a CELLfinity platform that delivers in vivo cell and gene therapies using a proprietary EXiVO automated approach…
SyngensysSyngensys develops synthetic gene promoters using transcriptional landscape analysis, computational design, selection, and validation to…
CaszymeCaszyme provides customized CRISPR solutions using a flexible platform and expertise in nucleases, mRNA, protein engineering, and evolution…
CiMaasCiMaas develops immunotherapy products that expand and engineer natural killer (NK) cells for adoptive cell therapy and CAR‑NK applications…
Oxford BiomedicaOxford Biomedica provides end-to-end CDMO services for cell and gene therapy clients, using lentivirus, AAV, and other viral vectors to…
- Asgard TherapeuticsAsgard Therapeutics develops AT-108, an off-the-shelf gene therapy using direct cell reprogramming to activate professional…
BIMINI BiotechBIMINI Biotech develops first-in-class small-molecule therapeutics targeting the Wiskott–Aldrich Syndrome protein for oncology and…